AMENDMENT NO. 1 TOAsset Purchase Agreement • July 23rd, 2019 • Achaogen, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 23rd, 2019 Company Industry JurisdictionThis Amendment No. 1 (this “Amendment”) to the Asset Purchase Agreement dated as of June 20, 2019, by and between Achaogen, Inc., a Delaware corporation (the “Seller”), and Cipla USA Inc., a Delaware corporation (the “Purchaser”), is made as of June 28, 2019. Purchaser and Seller are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.